$3,190.91 general Payment -- Gilead Sciences to Dr. Amy Phillips

Gilead Sciences Education Payment to HIV Medicine Physician Amy Phillips

This page provides a detailed analysis of a $3,190.91 general payment from Gilead Sciences to Dr. Amy Phillips. Data is from the CMS Open Payments (Sunshine Act) database.

Payment Details

Field	Value
Amount	$3,190.91
Payment Type	general
Payment Nature	Education
Pharmaceutical Company	Gilead Sciences
Physician	Dr. Amy Phillips
NPI Number	1993702483
Physician Specialty	HIV Medicine
Location	City, TN
Date of Payment	2024-10-03
Conflict Assessment	Low -- Routine

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

Gilead Sciences made a $3.2K general payment to Amy Phillips, a HIV Medicine specialist in City, TN. Gilead Sciences made a payment of $3,190.91 to Dr. Amy Phillips on October 3, 2024. The payment was categorized as 'Education' under the 'general' payment type. Dr. Phillips practices in HIV Medicine in City, TN.

Patient Guidance: What This Payment Means for You

This payment was for educational purposes and may involve information about Gilead Sciences' products or research. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

Payments for education can vary widely depending on the specialty and the nature of the educational activity.

Regulatory Context: Sunshine Act Requirements

This payment is reported under the Sunshine Act, requiring disclosure of payments made by drug and device manufacturers to physicians and teaching hospitals.

Understanding general Payments

general payments are one of several categories of financial transfers from pharmaceutical and medical device companies to physicians that must be reported under the Sunshine Act. Understanding the type and context of a payment is important for evaluating its significance. Not all payments are equal -- a research grant has very different implications than a promotional speaking fee.

Frequently Asked Questions About This Payment

What was this $3.2K payment for?

This was a general payment of $3.2K from Gilead Sciences to Amy Phillips, categorized as "Education". The payment was reported under the Sunshine Act (CMS Open Payments).

Does Amy Phillips accept pharmaceutical money?

Yes, Amy Phillips received this $3.2K payment from Gilead Sciences. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Amy Phillips's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this general payment?

A general payment of $3.2K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in HIV Medicine?

To compare this payment against HIV Medicine averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. HIV Medicine physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about Amy Phillips's relationship with Gilead Sciences?

The payment amount is $3,190.91. This $3.2K general payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for HIV Medicine?

The payment was made on October 3, 2024.

What should patients do after learning about this payment?

This payment was for educational purposes and may involve information about Gilead Sciences' products or research.

What else should I know about this general payment?

The payment was for 'Education'.

Related Reports

Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.